Literature DB >> 3894456

The significance of vitiligo antibodies.

J C Bystryn, G K Naughton.   

Abstract

Mesh：

Substances：

Year:  1985        PMID： 3894456     DOI： 10.1111/j.1346-8138.1985.tb01532.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN： 0385-2407            Impact factor:   4.005


× No keyword cloud information.
  5 in total

1.  Update on the genetics characterization of vitiligo.

Authors:  Hani A Al-Shobaili
Journal:  Int J Health Sci (Qassim)       Date:  2011-07

Review 2.  Tumor vaccines.

Authors:  J C Bystryn
Journal:  Cancer Metastasis Rev       Date:  1990-07       Impact factor: 9.264

3.  Vitiligo- and melanoma-associated hypopigmentation: a similar appearance but a different mechanism.

Authors:  O Merimsky; Y Shoenfeld; G Yecheskel; S Chaitchik; E Azizi; P Fishman
Journal:  Cancer Immunol Immunother       Date:  1994-06       Impact factor: 6.968

4.  Autoantibodies in vitiligo patients are not directed to the melanocyte differentiation antigen MelanA/MART1.

Authors:  E A Waterman; E H Kemp; D J Gawkrodger; P F Watson; A P Weetman
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

5.  Antimelanocyte Antibodies: A Possible Role in Patients with Vitiligo.

Authors:  Maha A El-Gayyar; Manal E Helmy; Eman R Amer; Moustafa A Elsaied; Mohammad A Gaballah
Journal:  Indian J Dermatol       Date:  2020 Jan-Feb       Impact factor: 1.494
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.